Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning
- 1 November 2002
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 30 (11) , 1346-1353
- https://doi.org/10.1016/s0301-472x(02)00923-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantationBlood, 2000
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1997
- T-cell depletion of HLA-identical transplants in leukemiaBlood, 1991
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- Treatment of Murine Leukaemia with X Rays and Homologous Bone MarrowBMJ, 1956